Atrapro Brand Launched for Skin and Wound Care

Quinnova has made available its Atrapro brand with two products, Atrapro Antipruritic Hydrogel and Atrapro Dermal Spray with Preservatives. Each product formulation features patented Microcyn, providing steroid-free, non-cytotoxic, and non-irritating relief.

Atrapro Antipruritic Hydrogel is indicated to relieve the pain, burning and itching associated with various dermatoses, including atopic dermatitis and radiation dermatitis. In a two-week clinical study involving 17 patients with pruritic atopic dermatitis, most patients reported itch relief within three days of initiating treatment with the product. Atrapro Antipruritic Hydrogel is available in a 4oz tube.

Atrapro Dermal Spray with Preservatives is indicated for the management via debridement of wounds such as stage I-IV pressure ulcers, partial- and full-thickness wounds, diabetic foot ulcers, post-surgical wounds, first- and second-degree burns, and grafted and donor sites. Atrapro Dermal Spray with Preservatives assists in the physical removal of biofilm, eliminates wound odor, and features a preservative system that is gentle and non-irritating to compromised tissue. Atrapro Dermal Spray with Preservatives is available in an 8oz finger-pump bottle.

For more information, call (877) 660-6263 or visit